Cargo Therapeutics (CRGX) shares tumbled 74% after the company said Wednesday it plans to discontinue a phase 2 study of firicabtagene autoleucel, or firi-cel, for patients with large B-cell lymphoma, and reduce its workforce by about 50% to preserve cash.
More than 17.3 million shares traded intraday compared with a daily average of about 313,000.
Ironwood Pharmaceuticals (IRWD) said late Wednesday it is reducing its workforce by about 50% because of "ongoing pricing pressures."
The company said the reorganization is expected to yield annual operating expense savings of about $55 million to $60 million and add $40 million to $45 million to annual profits.
Shares slumped 38% following a surge in intraday trading volume to over 7.3 million from a daily average of about 2 million.
United Parcel Service (UPS) issued a downbeat full-year revenue outlook after posting Q4 topline below market estimates on Thursday.
The company also expects a cut of more than 50% in volumes from its largest customer next year.
Shares sank 14%, with intraday trading volume catapulting to 31.6 million versus the stock's daily average of about 4.2 million.
Price: 3.39, Change: -9.80, Percent Change: -74.30
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.